Vilobelimab Completed Phase 2 Trials for Pyoderma Gangrenosum Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT03971643 | Exploratory Study of IFX-1 in Patients With Pyoderma Gangrenosum |
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT03971643 | Exploratory Study of IFX-1 in Patients With Pyoderma Gangrenosum |